Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Assets (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Assets for 16 consecutive years, with $615.7 million as the latest value for Q4 2025.

  • Quarterly Assets rose 11.58% to $615.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $615.7 million through Dec 2025, up 11.58% year-over-year, with the annual reading at $615.7 million for FY2025, 11.58% up from the prior year.
  • Assets for Q4 2025 was $615.7 million at Lemaitre Vascular, up from $598.1 million in the prior quarter.
  • The five-year high for Assets was $615.7 million in Q4 2025, with the low at $246.5 million in Q2 2021.
  • Average Assets over 5 years is $379.8 million, with a median of $330.2 million recorded in 2023.
  • The sharpest move saw Assets fell 3.6% in 2021, then surged 59.13% in 2024.
  • Over 5 years, Assets stood at $292.8 million in 2021, then grew by 6.04% to $310.5 million in 2022, then grew by 11.69% to $346.8 million in 2023, then soared by 59.13% to $551.8 million in 2024, then rose by 11.58% to $615.7 million in 2025.
  • According to Business Quant data, Assets over the past three periods came in at $615.7 million, $598.1 million, and $577.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.